| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 17 |
| 1 | CLOPIDOGREL BISULFATE | 16 |
| 2 | ACETAMINOPHEN | 13 |
| 3 | LEVETIRACETAM | 13 |
| 4 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| 5 | LEVETIRACETAM INJECTION | 13 |
| 6 | LEVETIRACETAM ORAL | 13 |
| 7 | ACETAMINOPHEN 500MG | 12 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 12 |
| 9 | BISOPROLOL FUMARATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0139 |
| 1 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 2 | SOLIFENACIN SUCCIATE | 2 | 0.0010 |
| 3 | IOMEPROL INJECTION | 1 | 0.0007 |
| 4 | ROPINIROLE HYDROCHLORIDE | 2 | 0.0005 |
| 5 | OSILODROSTAT | 1 | 0.0005 |
| 6 | DAPTOMYCIN | 4 | 0.0004 |
| 7 | LIDOCAINE HCL | 1 | 0.0004 |
| 8 | CAPTOPRIL | 3 | 0.0003 |
| 9 | IOVERSOL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 1 | P2Y12 Platelet Inhibitor [EPC] | 15 |
| 2 | Corticosteroid [EPC] | 14 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 11 |
| 4 | Platinum-based Drug [EPC] | 11 |
| 5 | Benzodiazepine [EPC] | 10 |
| 6 | Atypical Antipsychotic [EPC] | 8 |
| 7 | Proteasome Inhibitor [EPC] | 8 |
| 8 | Proton Pump Inhibitor [EPC] | 6 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipopeptide Antibacterial [EPC] | 4 | 0.0004 |
| 1 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 15 | 0.0001 |
| 3 | Radiographic Contrast Agent [EPC] | 3 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 6 | Glycopeptide Antibacterial [EPC] | 5 | 0.0001 |
| 7 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 9 | Proteasome Inhibitor [EPC] | 8 | 0.0001 |